Degradation of CFTR by the ubiquitin-proteasome pathway
- PMID: 7553863
- DOI: 10.1016/0092-8674(95)90240-6
Degradation of CFTR by the ubiquitin-proteasome pathway
Abstract
Most cases of cystic fibrosis are caused by mutations that interfere with the biosynthetic folding of the cystic fibrosis transmembrane conductance regulator (CFTR), leading to the rapid degradation of CFTR molecules that have not matured beyond the endoplasmic reticulum (ER). The mechanism by which integral membrane proteins including CFTR are recognized and targeted for ER degradation and the proteolytic machinery involved in this process are not well understood. We show here that the degradation of both wild-type and mutant CFTR is inhibited by two potent proteasome inhibitors that induce the accumulation of polyubiquitinated forms of immature CFTR. CFTR degradation was also inhibited by coexpression of a dominant negative ubiquitin mutant and in cells bearing a temperature-sensitive mutation in the ubiquitin-activating enzyme, confirming that ubiquitination is required for rapid CFTR degradation.
Similar articles
-
Multiple proteolytic systems, including the proteasome, contribute to CFTR processing.Cell. 1995 Oct 6;83(1):129-35. doi: 10.1016/0092-8674(95)90241-4. Cell. 1995. PMID: 7553864
-
The mechanism underlying cystic fibrosis transmembrane conductance regulator transport from the endoplasmic reticulum to the proteasome includes Sec61beta and a cytosolic, deglycosylated intermediary.J Biol Chem. 1998 Nov 6;273(45):29873-8. doi: 10.1074/jbc.273.45.29873. J Biol Chem. 1998. PMID: 9792704
-
COOH-terminal truncations promote proteasome-dependent degradation of mature cystic fibrosis transmembrane conductance regulator from post-Golgi compartments.J Cell Biol. 2001 May 28;153(5):957-70. doi: 10.1083/jcb.153.5.957. J Cell Biol. 2001. PMID: 11381082 Free PMC article.
-
Defects in processing and trafficking of the cystic fibrosis transmembrane conductance regulator.Kidney Int. 2000 Mar;57(3):825-31. doi: 10.1046/j.1523-1755.2000.00921.x. Kidney Int. 2000. PMID: 10720935 Review.
-
Cystic fibrosis: premature degradation of mutant proteins as a molecular disease mechanism.Methods Mol Biol. 2003;232:27-37. doi: 10.1385/1-59259-394-1:27. Methods Mol Biol. 2003. PMID: 12840537 Review. No abstract available.
Cited by
-
Development of CFTR Structure.Front Pharmacol. 2012 Sep 6;3:162. doi: 10.3389/fphar.2012.00162. eCollection 2012. Front Pharmacol. 2012. PMID: 22973227 Free PMC article.
-
Roles for the ubiquitin-proteasome pathway in protein quality control and signaling in the retina: implications in the pathogenesis of age-related macular degeneration.Mol Aspects Med. 2012 Aug;33(4):446-66. doi: 10.1016/j.mam.2012.04.001. Epub 2012 Apr 10. Mol Aspects Med. 2012. PMID: 22521794 Free PMC article. Review.
-
Potential for therapeutic manipulation of the UPR in disease.Semin Immunopathol. 2013 May;35(3):351-73. doi: 10.1007/s00281-013-0370-z. Epub 2013 Apr 10. Semin Immunopathol. 2013. PMID: 23572207 Free PMC article. Review.
-
Ubiquitination is essential for human cytomegalovirus US11-mediated dislocation of MHC class I molecules from the endoplasmic reticulum to the cytosol.Biochem J. 2001 Sep 1;358(Pt 2):369-77. doi: 10.1042/0264-6021:3580369. Biochem J. 2001. PMID: 11513735 Free PMC article.
-
ER-associated degradation in health and disease - from substrate to organism.J Cell Sci. 2019 Dec 2;132(23):jcs232850. doi: 10.1242/jcs.232850. J Cell Sci. 2019. PMID: 31792042 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases